← Open Payments lookup

DWIGHT KING: Open Payments

NPI 1679574313 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,573 in 193 payments from 18 companies in 2025. Trend: 2023 $2,716 · 2024 $2,825 · 2025 $3,573

Food & beverage: $3,573
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.13$449
E.R. Squibb & Sons, L.L.C.15$358
Neurocrine BioSciences, Inc.12$332
Alkermes, Inc.15$303
Otsuka America Pharmaceutical, Inc.15$288
Supernus Pharmaceuticals, Inc.30$248
Axsome Therapeutics, Inc.9$224
Teva Pharmaceuticals USA, Inc.12$215
Janssen Pharmaceuticals, Inc11$212
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$190

Products named: COBENFY, INGREZZA, REXULTI, Qelbree, ARISTADA, HETLIOZ, Auvelity, FANAPT.

Industry payments across DC — which companies pay providers there.